UNIGE document Scientific Article
previous document  unige:1430  next document
add to browser collection

Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets?

Published in Cancer Cell. 2008, vol. 14, no. 4, p. 281-3
Abstract Hedgehog (HH)-GLI signaling is a developmental patterning pathway used by many tumors for bulk proliferation that has been shown also to regulate cancer stem cell self-renewal and survival. Surprisingly, a recent study by Yauch et al. (2008) proposes that HH-GLI signaling acts only on the tumor stroma. The mode of action of HH-GLI signaling in cancer may shape the development of therapeutic antagonists.
Keywords AnimalsAntineoplastic Agents/pharmacologyCell Proliferation/drug effectsCell Survival/drug effectsEpithelial Cells/drug effects/metabolismHedgehog Proteins/metabolismHumansNeoplasms/drug therapy/metabolism/pathologyNeoplastic Stem Cells/drug effects/metabolismParacrine Communication/drug effectsReceptors, G-Protein-Coupled/antagonists & inhibitors/metabolismSignal Transduction/drug effectsStromal Cells/drug effects/metabolismTranscription Factors/metabolism
Stable URL https://archive-ouverte.unige.ch/unige:1430
Full text
Article (Author postprint) (237 Kb) - document accessible for UNIGE members only Limited access to UNIGE
PMID: 18835029
Research group Morphologie de l'organisme et rôle des protéines GLI (776)

197 hits



Deposited on : 2009-04-28

Export document
Format :
Citation style :